Prof. Francesca Montagnani is currently Assistant Professor and Researcher of Infectious Diseases at the Dept. Medical Biotechnologies of University of Siena and Medical Doctor at Tropical and Infectious Diseases Unit, Hospital Department of Specialized and Internal Medicine, Siena University Hospital, Siena,Italy. She is graduated in 1998 at the University of Siena (Italy) in Medical School with 110/110 “summa cum laude”, and specialized in Infectious Diseases at the University of Siena, in 2002. She has a PhD in “Medical Biotechnologies, section Microbic Biotechnology Vaccines and Infectious Diseases” at the University of Siena. She worked in the adult and pediatric infectious diseases wards and in the microbiological laboratory of the clinic taking part to clinical, diagnostic and research activities. She actually works in adult infectious diseases wards and Day Hospital with inpatients, Day Service for outpatients and she acts as infectious diseases consultant for all wards into the Hospital. Her main research activities focus on the study of the clinical-epidemiological implications of chemoresistances, of diagnostic methods in bacterial infections and of prevention strategy in immunosuppressed subjects, such has HIV and lung transplant recipients; she also participates to clinical studies on HIV and HCV therapeutic optimization strategy.

Dr. Barbara Rossetti is currently a consultant in Tropical and Infectious Diseases Unit at Siena University Hospital, Siena Italy, taking part to clinical, diagnostic and research activities. She graduated with honor in Medicine at the University of Siena in 2007. In 2012 she received a specialist degree in Infectious Diseases at the University of Siena. In 2015, she completed a PhD in Cellular and Molecular Clinical Research, at Catholic University of Sacred Heart, Faculty of Medicine, Rome, Italy. She focused her research on HIV, HCV and HBV antiviral strategies including salvage therapy studies and treatment switch or simplification studies in HIV. She was involved in several studies concerning HIV and HCV drug resistance in treatment-naïve and experienced patients and in some observational studies regarding bacterial epidemiology and novel antibacterials efficacy. She took part to several Italian and European cohort studies on the impact of comorbidities in HIV and on the impact of hepatitis virus co-infections.

Dr. Massimiliano Fabbiani is currently an Infectious Diseases Consultant at the Infectious and Tropical Diseases Unit of the Siena University Hospital, Italy. He graduated in 2003 at the University of Siena (Italy) in Medical School with 110/110 “summa cum laude”, and specialized in Infectious Diseases at the University of Siena (2007). He got a PhD in “Biology and Clinic of Tropical and Infectious Diseases” at the Catholic University of Sacred Heart, Rome, Italy (2011). His research activities are mostly focused on HIV infection, HIV drug resistance, antiretroviral therapy and clinical pharmacology of antiretroviral drugs. He also conducted researches investigating hepatitis infection and HBV immunization, influenza vaccination, epidemiology of influenza virus and other paediatric viral respiratory tract infections, epidemiology of tuberculosis, antibiotic resistance. He coordinated and collaborated to several clinical trials. His research activity is documented by peer-reviewed publications and studies presented at national and international conferences.

“Dr. Ilaria Rancan graduated with honours in Medicine and Surgery at the University of Florence in 2020. She is currently a resident in Infectious and Tropical Diseases at Siena University Hospital.”